Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 82.17B | 78.95B | 92.88B | 102.67B | 96.55B | 64.23B |
Gross Profit | 15.73B | 32.47B | 31.69B | 24.75B | 30.96B | 23.27B |
EBITDA | 25.73B | 22.02B | 18.30B | 18.18B | 13.70B | 14.08B |
Net Income | 7.09B | 7.02B | 3.44B | 1.68B | 3.19B | 3.62B |
Balance Sheet | ||||||
Total Assets | 185.19B | 187.14B | 195.22B | 219.62B | 206.94B | 163.45B |
Cash, Cash Equivalents and Short-Term Investments | 11.51B | 8.05B | 11.33B | 24.79B | 11.02B | 6.37B |
Total Debt | 69.22B | 71.08B | 73.56B | 87.91B | 70.92B | 58.66B |
Total Liabilities | 132.44B | 137.97B | 150.12B | 177.54B | 164.60B | 121.10B |
Stockholders Equity | 37.11B | 33.73B | 25.20B | 28.66B | 29.65B | 28.32B |
Cash Flow | ||||||
Free Cash Flow | 4.36B | 4.29B | 1.85B | -4.57B | -2.13B | 1.96B |
Operating Cash Flow | 12.03B | 13.22B | 14.62B | 8.67B | 10.07B | 11.51B |
Investing Cash Flow | -4.75B | -4.11B | -10.61B | -13.63B | -10.88B | -10.12B |
Financing Cash Flow | -6.83B | -7.99B | -8.36B | 7.37B | 3.78B | -3.97B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
76 Outperform | €80.44B | 11.34 | 25.20% | 5.66% | -7.85% | 63.65% | |
71 Outperform | €13.05B | 45.54 | 11.98% | 4.57% | 1.73% | 7.18% | |
70 Outperform | €4.20B | 12.11 | 13.68% | 4.86% | -2.19% | 14.21% | |
70 Neutral | €3.28B | 11.64 | 8.81% | 4.95% | 9.09% | 16.49% | |
69 Neutral | €5.81B | 11.37 | 13.57% | 3.77% | 10.92% | 29.39% | |
68 Neutral | €6.81B | 8.23 | 16.17% | 4.52% | 2.73% | 6.02% |